Profiling of Mutations in the F8 and F9, Causative Genes of Hemophilia A and Hemophilia B
نویسندگان
چکیده
Hemophilia, a common congenital coagulation disorder, is classified as hemophilia A (HA) and hemophilia B (HB), which result from a deficiency or dysfunction of coagulation factor VIII (FVIII) and factor IX (FIX), respectively. HA is known to be caused by heterogeneous mutations of the FVIII gene (F8), such as inversions, substitutions, deletions, insertions, etc. F8 (NM_000132.3) is located on the long arm of the Xq28 region of the X chromosome. F8 is extremely large (186 kb) and consists of 26 exons (Graw et al., 2005). The transcript of F8 is approximately 9010 bp and comprises a short 5′-untranslated region (5′-UTR; 150 bp), an open reading frame (ORF) plus stop codon (7056 bp), and a long 3′-UTR (1806 bp). The protein product of F8 is a cofactor of FIX, without enzyme activity. The ORF encodes a signal peptide with 19 amino acids at its N-terminus, which leads to the passage of FVIII through hepatocytes to blood vessels. The matured FVIII protein contains 2332 amino acids and a glycoprotein of approximately 250 kDa, and circulates as an inactive pro-cofactor. FVIII is a multi-domain protein composed of A1-A2-B-A3-C1-C2, named from the Nterminus. FVIII synthesized in hepatocytes is secreted into the circulation and readily assembled with von Willebrand factor (vWF), which is generated and secreted by endothelial cells. Besides vWF, FVIII protein can also interact with diverse proteins such as thrombin and FX. These interactions are important for effective hemostasis. However, F8 mutations can lead to the production of truncated proteins, which lead to disruption of FVIII function and suppress normal protein interaction with proteins involved in the coagulation cascade (Bowen, 2002). This inappropriate reaction causes bleeding tendency. F8 mutations can occur at diverse sites in a variety of types, such as structural variation (inversions of intron 22 or intron 1) and sequence variation (insertion, deletion, and substitution). The latter variation leads to nonsense, missense, and frameshift mutations. Recently, more than 1,200 types of F8 mutations were reported in the HAMSTeRS (Hemophilia A Mutation, Structure, Test and Resource Site) database (http://hadb.org.uk). The F9 gene (NM_000133.3) is also located on the X chromosome at Xq27.1–q27.2. In contrst to F8, the size of F9 gene is approximately 34 kb with only eight exons and the size of the transcript mRNA is 2803 bp. The F9 gene encodes the FIX protein, one of the vitamin
منابع مشابه
Recent Advances in Hemophilia Gene Therapy
Heterogeneous loss of function mutations at F8 and F9 genes causes X-linked recessive bleeding disorders, hemophilia A (HA) and hemophilia B (HB), respectively. HA is clinically indistinguishable from HB and accounts for more than 80% of hemophilia cases; the former affects 1/5000 and the latter 1/25000 male births worldwide. In Iran, it is estimated that around 4300 HA and 900 HB patients are ...
متن کاملUtility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening.
Hemophilia A (HA) and B (HB) are estimated to affect 1 in 5,000 male births in the United States each year.[1] Inheritance of mutations in the Factor VIII (F8) gene or Factor IX (F9) gene causes these bleeding disorders. Identification of mutations causing a patient’s hemophilia can lead to better understanding of risk of complications [2], as well as aid in carrier detection in family members ...
متن کاملGene Expression under F8 Promoter Driving In Mouse Hepatoma Cells: A Step towards Gene Therapy of Hemophilia
Background and Objectives: Significant progress has been made in treatment of hemophilia. Ex-vivo gene therapy is going popular due to the capability of this method in using isogenic cells for genetic manipulation and reintroducing them into same host after proliferation. Most gene therapy techniques use viral vectors, which usually harbor a strong and non-specific promoter (e...
متن کاملSequence variation data of F8 and F9 genes in functionally validated control individuals: implications on the molecular diagnosis of hemophilia
BACKGROUND The F8 and F9 genes encode for coagulation factor VIII (FVIII) and FIX, respectively, and mutations in these genes are the genetic basis of hemophilia A/B. To determine whether a sequence variation in F8/F9 is a disease-causing mutation, frequency data from a control population is needed. This study aimed to obtain data on sequence variation in F8/F9 in a set of functionally validate...
متن کاملMolecular Characterization of the Factor IX Gene in 28 Iranian Hemophilia B Patients
Background: Heterogeneous mutations in the human coagulation factor IX gene lead to an X-linked recessive bleeding disorder known as hemophilia B. The disease is distributed worldwide with no ethnic or geographical priority. Materials and Methods: The aim of this study was to characterize the factor IX gene mutations in 28 unrelated Iranian hemophilia B patients. Polymerase chain reaction (PCR)...
متن کامل